ITRM20000129A0 - USE OF SPIROLAXIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ALTERED ANGIOGENESIS. - Google Patents

USE OF SPIROLAXIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ALTERED ANGIOGENESIS.

Info

Publication number: ITRM20000129A0
Authority: IT; Italy
Prior art keywords: spirolaxin; treatment; diseases associated; altered angiogenesis; angiogenesis
Prior art date: 2000-03-13

Application number

IT2000RM000129A

Other languages

Italian (it)

Original Assignee

Sigma Tau Ind Farmaceuti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-13

Filing date

2000-03-13

Publication date

2000-03-13

2000-03-13 Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti

2000-03-13 Priority to IT2000RM000129A priority Critical patent/IT1317001B1/en

2000-03-13 Publication of ITRM20000129A0 publication Critical patent/ITRM20000129A0/en

2001-03-07 Priority to PCT/IT2001/000113 priority patent/WO2001068070A2/en

2001-03-07 Priority to AU44533/01A priority patent/AU4453301A/en

2001-09-13 Publication of ITRM20000129A1 publication Critical patent/ITRM20000129A1/en

2003-05-26 Application granted granted Critical

2003-05-26 Publication of IT1317001B1 publication Critical patent/IT1317001B1/en

Links

CZIMFHQXGMXDMO-DGROVODQSA-N (3r)-5-hydroxy-7-methoxy-3-[5-[(2r,5r,7r)-2-methyl-1,6-dioxaspiro[4.5]decan-7-yl]pentyl]-3h-2-benzofuran-1-one Chemical compound C([C@H](O1)CCCCC[C@@H]2C=3C=C(O)C=C(C=3C(=O)O2)OC)CC[C@@]21CC[C@@H](C)O2 CZIMFHQXGMXDMO-DGROVODQSA-N 0.000 title 1
230000033115 angiogenesis Effects 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IT2000RM000129A 2000-03-13 2000-03-13 USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS. IT1317001B1 (en)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
IT2000RM000129A IT1317001B1 (en)	2000-03-13	2000-03-13	USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.
PCT/IT2001/000113 WO2001068070A2 (en)	2000-03-13	2001-03-07	Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis
AU44533/01A AU4453301A (en)	2000-03-13	2001-03-07	Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT2000RM000129A IT1317001B1 (en)	2000-03-13	2000-03-13	USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.

Publications (3)

Publication Number	Publication Date
ITRM20000129A0 true ITRM20000129A0 (en)	2000-03-13
ITRM20000129A1 ITRM20000129A1 (en)	2001-09-13
IT1317001B1 IT1317001B1 (en)	2003-05-26

Family

ID=11454527

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT2000RM000129A IT1317001B1 (en)	2000-03-13	2000-03-13	USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.

Country Status (3)

Country	Link
AU (1)	AU4453301A (en)
IT (1)	IT1317001B1 (en)
WO (1)	WO2001068070A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITRM20010136A1 (en) *	2001-03-16	2002-09-16	Sigma Tau Ind Farmaceuti	USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES THAT RESPOND TO THE ACTIVATION OF THE PPAR-GAMMA RECEPTOR.
ITMI20041279A1 (en) *	2004-06-24	2004-09-24	Pharmaproducts Uk Ltd	USE OF TRIFLUOROACETATE CALCIUM FOR THE PREPARATION OF ANTI-ANGIOGENETIC EFFECT MEDICATIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6174710B1 (en) *	1994-08-09	2001-01-16	Pfizer Inc.	Spirolaxine derivatives for treating gastrobuodenal diseases
JPH107557A (en) *	1996-06-17	1998-01-13	Banyu Pharmaceut Co Ltd	Spirolaxine, an antitumor substance
IL140729A0 (en) *	1998-07-14	2002-02-10	Bristol Myers Squibb Co	Lysine binding fragments of angiostatin, pharmaceutical compositions containing the same and processes for the preparation thereof

2000
- 2000-03-13 IT IT2000RM000129A patent/IT1317001B1/en active
2001
- 2001-03-07 WO PCT/IT2001/000113 patent/WO2001068070A2/en not_active Ceased
- 2001-03-07 AU AU44533/01A patent/AU4453301A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2001068070A2 (en)	2001-09-20
ITRM20000129A1 (en)	2001-09-13
IT1317001B1 (en)	2003-05-26
WO2001068070A3 (en)	2002-04-18
WO2001068070A8 (en)	2001-11-08
AU4453301A (en)	2001-09-24

Publication	Publication Date	Title
DE50112057D1 (en)	2007-04-05	Cleaning-friendly glass ceramic body
DE60116219D1 (en)	2006-02-02	The disposable panty
DE60131349D1 (en)	2007-12-27	The disposable panty
DE60125877D1 (en)	2007-02-22	The disposable panty
MA25413A1 (en)	2002-04-01	MANUFACTURE OF THERAPEUTIC MICROMOUSSE.
BR0103754B1 (en)	2009-01-13	disposable article.
BR0212684B1 (en)	2012-06-26	single use retractable syringe.
DE60112823D1 (en)	2005-09-29	The disposable panty
DE60113605D1 (en)	2006-02-09	About Streif disposable undergarment
BR0200521B1 (en)	2011-01-25	toilet article.
DE60105336D1 (en)	2004-10-14	The disposable panty
ITNA20000036A0 (en)	2000-06-02	NEW THERAPEUTIC APPROACHES FOR THE TREATMENT OF DANDRUFF.
BR0100928B1 (en)	2010-06-15	sanitary napkin.
IT249776Y1 (en)	2003-05-28	MONOLITHIC THROUGH INSULATOR
DE60105369D1 (en)	2004-10-14	The disposable panty
ITRM20010708A0 (en)	2001-12-04	USE OF ALCANOYL L-CARNITINE FOR THE TREATMENT OF ERECTILE DYSFUNCTION.
ITRM20000129A0 (en)	2000-03-13	USE OF SPIROLAXIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ALTERED ANGIOGENESIS.
NO20023517D0 (en)	2002-07-24	Chair
IT1319686B1 (en)	2003-10-23	CITALOPRAM PREPARATION PROCEDURE.
ITRM20010293A0 (en)	2001-05-29	USE OF ACETYL-L-CARNETINE FOR THE PREPARATION OF A MEDICINES FOR THE PREVENTION OF PAIN.
IT1320253B1 (en)	2003-11-26	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MALARIA.
NL1014850A1 (en)	2001-10-09	Coffin.
BR8001776Y1 (en)	2008-11-18	Sunbed chair.
IT249404Y1 (en)	2003-05-07	CHAIR STRUCTURE.
ITIS20000001U1 (en)	2001-08-21	IDENTIFIABLE DISPOSABLE GLASS.

ITRM20000129A0 - USE OF SPIROLAXIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ALTERED ANGIOGENESIS. - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (3)

Applications Claiming Priority (1)

Publications (3)

Family

ID=11454527

Family Applications (1)

Country Status (3)

Families Citing this family (2)

Family Cites Families (3)

Also Published As

Similar Documents